| 2017-01 | Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase | Jang, Yura; Chung, Hye Jin; Hong, Jung Wan; Yun, Cheol-Won; Chung, Hesson |
| 2005-10 | Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel | Lee, SJ; Kim, SW; Chung, H; Park, YT; Choi, YW; Cho, YH; Yoon, MS |
| 2018-08 | Controlled release of paclitaxel using a drug-eluting stent through modulation of the size of drug particles in vivo | Jang, Bu Nam; Kang, Sung Nam; Eom, Tae-Gwan; Han, Dong Keun; An, Sang-Hyun; Noh, Insup; Kum, Chang Hun |
| 2012-04 | Development, Optimization and Absorption Mechanism of DHP107, Oral Paclitaxel Formulation for Single-Agent Anticancer Therapy | In-Hyun Lee; Jung Wan Hong; Jang Yura; Yeong Taek Park; Chung, Hesson |
| 2018-07 | Dual-Layer Coated Drug-Eluting Stents with Improved Degradation Morphology and Controlled Drug Release | Bedair, Tarek M.; Park, Wooram; Park, Bang-Ju; Moon, Myoung-Woon; Lee, Kwang-Ryeol; Joung, Yoon Ki; Han, Dong Keun |
| - | Effect of P-glycoprotein on the tissue distribution of DHP107, oral paclitaxel formulation | HONG JUNG WAN; Chung, Hye Jin; Lee, In Hyun; Kwak, Young Hak; Park, Yeong Tack; Sung, Ha Chin; Chung, Hesson |
| 2007-12 | Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation | Hong, Jung Wan; Lee, In-Hyun; Kwak, Young Hak; Park, Young Taek; Sung, Ha Chin; Kwon, Ick Chan; Chung, Hesson |
| 2007-06-29 | Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation | Yang, Tao; Cui, Fu-De; Choi, Min-Koo; Cho, Jei-Won; Chung, Suk-Jae; Shim, Chang-Koo; Kim, Dae-Duk |
| 2012-02 | Enhancement of the Targeting Capabilities of the Paclitaxel-Loaded Pluronic Nanoparticles with a Glycol Chitosan/Heparin Composite | Yuk, Soon Hong; Oh, Keun Sang; Cho, Sun Hang; Kim, Sang Yoon; Oh, Sangkwon; Lee, Jin Ho; Kim, Kwangmeyung; Kwon, Ick Chan |
| 2009-02 | Evaluation of the Anti-Tumor Effects of Paclitaxel-Encapsulated pH-Sensitive Micelles | Han, Jong Kwon; Kim, Min Sang; Lee, Doo Sung; Kim, Yoo-Shin; Park, Rang-Woon; Kim, Kwangmeyung; Kwon, Ick Chan |
| 2013-02 | Heparin-Conjugated Pluronic Nanogels as Muiti-Drug Nanocarriers for Combination Chemotherapy | Joung, Yoon Ki; Jang, Ji Young; Choi, Jong Hoon; Han, Dong Keun; Park, Ki Dong |
| 2006-03-10 | Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel (Reprinted from Journal of Controlled Release, vol 109, pg 1, 2005) | Kim, JH; Kim, YS; Kim, S; Park, JH; Kim, K; Choi, K; Chung, H; Jeong, SY; Park, RW; Kim, IS; Kwon, IC |
| 1999-12 | I-123 labelled paclitaxel | Roh, E.J.; Park, Y.H.; Oh, C.R.; Song, C.E.; Oh, S.-J.; Choe, Y.S.; Kim, B.-T.; Chi, D.Y.; Kim, D. |
| 2020-07 | KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors | 이진주; Ahn Hyung Jun |
| 2001-09 | Lipid cubic phase-related structures as drug delivery systems | 정혜선; 김지선; 김희경; 권익찬; 정서영 |
| - | Local and oral paclitaxel delivery systems | 박희성; 이인현; Young Man Kim; 정진욱; 윤창진; PARK JAE HYUNG; Kwon Ick Chan; Jeong Seo Young; 윤순홍; 최영유; 김세웅; 김길수; Chung Hesson |
| 2023-07 | Microwave-Assisted Synthesis of Porous Biomolecule-Incorporated Metal-Organic Frameworks as Efficient Nanocarriers for Anti-Cancer Drugs | Nguyen, Trang Thi Thu; Le, Bao Quang Gia; Nguyen, Vy Tran Hanh; Lee, Jae-Hyoung; Mai, Ngoc Xuan Dat; Nguyen, Linh Ho Thuy; Doan, Tan Le Hoang |
| 2020-04-06 | Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma | Ullah, Irfan; Chung, Kunho; Bae, Sumin; Li, Yan; Kim, Chunggu; Choi, Boyoung; Nam, Hye Yeong; Kim, Sun Hwa; Yun, Chae-Ok; Lee, Kuen Yong; Kumar, Priti; Lee, Sang-Kyung |
| - | Oral paclitaxel delivery systems | 이인현; 박희성; Young Man Kim; Kwon Ick Chan; Jeong Seo Young; Chung Hesson |
| 2002-12 | Paclitaxel solubilized in lipiodol for the treatment of hepatoma | 이인현; 박희성; 정진욱; 박재형; 박영택; 권익찬; 정서영; 정혜선 |
| 2007-02-22 | pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel | Shim, Woo Sun; Kim, Jong-Ho; Kim, Kwangmeyung; Kim, Yoo-Shin; Park, Rang-Woon; Kim, In-San; Kwon, Ick Chan; Lee, Doo Sung |
| - | Pharmacokinetic study of paclitaxel with biodegradable polymers | Kim Sieun; Park Chul Ho; Lee Bong Soo; Park Kwi Deok; Dong Keun Han |
| - | Pharmacokinetics of Paclitaxel with a Novel Lipid-Based Formulation, DHP107 in Mice and Dogs | Chung, Hye Jin; HONG JUNG WAN; Park, Yeong Tack; Chung, Hesson |
| - | Poly(2-ethyl-2-oxazoline(-b-poly( ε -caprolactone) copolymer micelles as a carrier for paclitaxel | 이상천; Kwon Ick Chan; Chung Hesson; 김철희; Jeong Seo Young |
| 2003-05-20 | Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel | Lee, SC; Kim, C; Kwon, IC; Chung, H; Jeong, SY |
| - | Radiolabelling of paclitaxel with electrophilic ¹²³I | Song Choong Eui; ROH EUN JOO; 박영훈; 오승준; 최연성; 김병태; JI DAE YOON; 김득준 |
| 2004-04 | Single and two-week repeated oral dose toxicity study pf DHP2, a hydrophobic drug delivery vehicle in mice | 한정희; 정혜선; 이종화; 서정은; 이갑수; 김종춘; 강부현 |
| 2003-11 | Stable emulsions of paclitaxel and anticancer agents for chemoembolization | 이인현; 노경호; 권익찬; 정서영; 정진욱; 박재형; 박영택; 정혜선 |
| 2005-02-02 | Stable paclitaxel formulations in oily contrast medium | Lee, IH; Park, YT; Roh, K; Chung, H; Kwon, IC; Jeong, SY |
| - | Study on the release behavior of paclitaxel from various biodegradable polymers | Kim Sieun; Lee Bong Soo; Park Kwi Deok; Dong Keun Han |
